Importantly, treatment of two different Pkd1-mouse models of ADPKD with 2-deoxyglucose, an inhibitor of glycolysis showed beneficial results with lower kidney weight and volume and normalized AMP-activated protein kinase and its target acetyl-CoA carboxylase [89,91]. Here, PKD1 is linked to autosomal dominant polycystic kidney disease.